Show Summary Details
Page of

Screening and surveillance 

Screening and surveillance
Chapter:
Screening and surveillance
Author(s):

Mike Rayner

, Kremlin Wickramasinghe

, Julianne Williams

, Karen McColl

, and Shanthi Mendis

DOI:
10.1093/med/9780198791188.003.0007
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 11 July 2020

This chapter discusses screening and surveillance and the role that these activities play in tackling non-communicable diseases. Screening and surveillance have an important role in all stages of the policy cycle. This chapter outlines the differences among screening, surveillance, and monitoring and how they help to define the problem, formulate strategies, monitor their successful implementation, and provide feedback. This chapter provides information about how these programmes could be integrated with risk categorization to identify high-risk groups for targeted interventions. It also discusses the types of surveillance and different ways to use surveillance data. It provides several case studies on screening and surveillance programmes set up in different parts of the world.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.